Assessment of immunogenicity and protective efficacy of Microsporum canis secreted components coupled to monophosphoryl lipid-A adjuvant in a vaccine study using guinea pigs.

[1]  N. Antoine,et al.  Feline polymorphonuclear neutrophils produce pro-inflammatory cytokines following exposure to Microsporum canis. , 2013, Veterinary microbiology.

[2]  N. Antoine,et al.  Subtilisin Sub3 is involved in adherence of Microsporum canis to human and animal epidermis. , 2012, Veterinary microbiology.

[3]  R. Xavier,et al.  Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. , 2012, Cell host & microbe.

[4]  M. Monod,et al.  Zoonotic infections with dermatophyte fungi , 2011 .

[5]  E. Sherwood,et al.  The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid A Augments Innate Host Resistance to Systemic Bacterial Infection , 2011, Infection and Immunity.

[6]  M. Netea,et al.  Trained immunity: a memory for innate host defense. , 2011, Cell host & microbe.

[7]  D. Carlotti,et al.  Eradication of feline dermatophytosis in a shelter: a field study. , 2010, Veterinary dermatology.

[8]  M. Galleni,et al.  Secreted subtilisin Sub3 from Microsporum canis is required for adherence to but not for invasion of the epidermis , 2010, The British journal of dermatology.

[9]  R. Mueller,et al.  Treatment of Feline Dermatophytosis with an Inactivated Fungal Vaccine , 2010 .

[10]  Hongshan Liu,et al.  Intrauterine hypoxia upregulates proinflammatory cytokines and matrix metalloproteinases in fetal guinea pig hearts. , 2008, American journal of obstetrics and gynecology.

[11]  S. Almeida,et al.  Immunology of Dermatophytosis , 2008, Mycopathologia.

[12]  D. DeBoer,et al.  Immunoprophylaxis of Dermatophytosis in Animals , 2008, Mycopathologia.

[13]  J. Bouchara,et al.  Updates on the Epidemiology of Dermatophyte Infections , 2008, Mycopathologia.

[14]  B. Losson,et al.  Immunization and dermatophytes , 2008, Current opinion in infectious diseases.

[15]  Alberto Mantovani,et al.  Macrophage receptors implicated in the "adaptive" form of innate immunity. , 2007, Microbes and infection.

[16]  B. Losson,et al.  Reconstructed interfollicular feline epidermis as a model for Microsporum canis dermatophytosis. , 2007, Journal of medical microbiology.

[17]  M. Russo,et al.  Stimulation, inhibition and death of macrophages infected with Trichophyton rubrum. , 2006, Microbes and infection.

[18]  Bruce S. Thompson,et al.  The low‐toxicity versions of LPS, MPL® adjuvant and RC529, are efficient adjuvants for CD4+ T cells , 2005, Journal of leukocyte biology.

[19]  R. Milan,et al.  Recombinant protein and DNA vaccines derived from hsp60 Trichophyton mentagrophytes control the clinical course of trichophytosis in bovine species and guinea‐pigs , 2004, Mycoses.

[20]  K. Moriello.  Treatment of dermatophytosis in dogs and cats: review of published studies. , 2004, Veterinary dermatology.

[21]  B. Losson,et al.  Evaluation of immunogenicity and protective efficacy of a Microsporum canis metalloprotease subunit vaccine in guinea pigs. , 2004, FEMS immunology and medical microbiology.

[22]  B. Losson,et al.  A recombinant 31.5 kDa keratinase and a crude exo-antigen from Microsporum canis fail to protect against a homologous experimental infection in guinea pigs. , 2003, Veterinary dermatology.

[23]  D. McMurray,et al.  Coordinate Cytokine Gene Expression In Vivo following Induction of Tuberculous Pleurisy in Guinea Pigs , 2003, Infection and Immunity.

[24]  D. DeBoer,et al.  Safety and immunologic effects after inoculation of inactivated and combined live-inactivated dermatophytosis vaccines in cats. , 2002, American journal of veterinary research.

[25]  G. Piérard,et al.  Humoral and cellular immune response to a crude exo-antigen and purified keratinase of Microsporum canis in experimentally infected guinea pigs. , 1999, Medical mycology.

[26]  P. van Damme,et al.  Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system. , 1998, Vaccine.

[27]  B. Elewski.  Cutaneous Fungal Infections , 1998 .

[28]  B. Losson,et al.  Prevalence and characterization of Microsporum canis carriage in cats. , 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[29]  T. Platts-Mills,et al.  Definition of a Trichophyton protein associated with delayed hypersensitivity in humans. Evidence for immediate (IgE and IgG4) and delayed hypersensitivity to a single protein. , 1996, Journal of immunology.

[30]  D. DeBoer,et al.  Investigations of a killed dermatophyte cell-wall vaccine against infection with Microsporum canis in cats. , 1995, Research in veterinary science.

[31]  C. Cockerell.  Cutaneous fungal infections in HIV/AIDS. , 1995, Journal of the International Association of Physicians in AIDS Care.

[32]  D. Elad,et al.  Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: a field trial. , 1995, Vaccine.

[33]  D. DeBoer,et al.  The Immune Response to Microsporum canis Induced by a Fungal Cell Wall Vaccine , 1994 .

[34]  D. Elad,et al.  Immunogenicity in guinea-pigs of a crude ribosomal fraction from Microsporum canis. , 1994, Vaccine.

[35]  C. Stokes,et al.  Humoral immune responses in cats with dermatophytosis. , 1993, American journal of veterinary research.

[36]  M. Tomai,et al.  Characterization of a nontoxic monophosphoryl lipid A. , 1987, Reviews of infectious diseases.

[37]  R. Gudding,et al.  Vaccination of cattle against ringworm caused by Trichophyton verrucosum. , 1986, American journal of veterinary research.